Nuveen AMT-Free Municipal Credit Income Fund (NVG) Stock Price

12.71 ▼ -0.08 (-0.63%)
Open: 12.74 Vol: 437.6K Day's range: 12.66 - 12.74 Mar 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NVG Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.70▲ 12.69▲ 12.69▲ 12.84▼ 13.11▼
MA10 12.69▲ 12.69▲ 12.71▼ 12.93▼ 12.97▼
MA20 12.69▲ 12.73▼ 12.78▼ 13.14▼ 12.78▼
MA50 12.74▼ 12.83▼ 12.85▼ 12.96▼ 12.28▲
MA100 12.82▼ 12.89▼ 13.05▼ 12.76▼ 12.43▲
MA200 12.84▼ 13.09▼ 13.09▼ 12.35▲ 12.20▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.007▲ 0.004▲ -0.006▼ -0.070▼ -0.006▼
RSI 48.368▼ 35.713▼ 29.612▼ 31.460▼ 50.511▲
STOCH 95.238▲ 47.580     10.842▼ 14.763▼ 63.017    
WILL %R 0.000▲ -69.565     -78.125▼ -93.902▼ -75.498▼
CCI 93.333     8.473     -48.445     -113.831▼ -23.393    
Latest Filters Detected On NVG
▼ BREAK $NVG Price Breaks 20 Days Low Set Alert
▼ BREAK $NVG Price Breaks 10 Days Low Set Alert
CDL $NVG Hammer Candlestick Pattern Detected Set Alert
Nuveen AMT-Free Municipal Credit Income Fund News
NervGen Pharma Corp.: NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
Friday, March 13, 2026 03:28 AM
The Company's common shares will continue to trade on Nasdaq under the symbol "NGEN"No action is required; all shareholders, including Canadian shareholders, will continue to maintain full trading acc ...
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
Thursday, March 12, 2026 01:16 PM
The Company’s common shares will continue to trade on Nasdaq under the symbol “NGEN” No action is required; all shareholders, including Canadian shareholders, will continue to maintain full trading ...
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
Wednesday, March 04, 2026 04:38 AM
NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury ...
NVG historical stock data
date open high low close volume
13/03/26 12.74 12.74 12.66 12.71 437,600
12/03/26 12.855 12.855 12.735 12.79 537,259
11/03/26 12.93 12.955 12.86 12.89 454,391
10/03/26 12.92 12.94 12.88 12.93 625,457
09/03/26 12.89 12.91 12.855 12.87 544,221
06/03/26 12.84 12.90 12.7845 12.89 581,680
05/03/26 12.97 12.97 12.85 12.89 999,600
04/03/26 13.15 13.15 12.98 13.01 603,973
03/03/26 13.19 13.19 13.09 13.13 881,480
02/03/26 13.29 13.29 13.14 13.22 1,022,257
Quote Details
52wk Low:11.00
52wk High:13.59
Vol:437.6K
Avg Vol(3m):11.3M
1Y Chng:+2.67%
1M Chng:-1.09%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 2.89B